ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Anebulo Pharmaceuticals Inc

Anebulo Pharmaceuticals Inc (ANEB)

1.54
-0.04
(-2.53%)
終了 1月27日 6:00AM
1.45
-0.09
(-5.84%)
取引時間後: 9:59AM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
1.54
買値
1.22
売値
1.62
出来高
18,618
1.45 日の範囲 1.5877
0.8001 52 週間の範囲 3.30
時価総額
前日終値
1.58
始値
1.57
最終取引時間
財務取引量
US$ 27,609
VWAP
1.4829
平均取引量 (3 か月)
30,515
発行済株式数
25,933,217
配当利回り
-
PER
-4.58
1 株当たり利益 (EPS)
-0.32
歳入
-
純利益
-8.2M

Anebulo Pharmaceuticals Inc について

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of admini... Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Dover, Delaware, USA
設立
-
Anebulo Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker ANEB. The last closing price for Anebulo Pharmaceuticals was US$1.58. Over the last year, Anebulo Pharmaceuticals shares have traded in a share price range of US$ 0.8001 to US$ 3.30.

Anebulo Pharmaceuticals currently has 25,933,217 shares in issue. The market capitalisation of Anebulo Pharmaceuticals is US$40.97 million. Anebulo Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.58.

ANEB 最新ニュース

Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid-induced toxicities (the “Company”...

Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or...

Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company”...

Anebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic Effects

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company”...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.15-8.875739644971.691.691.4599261.64673837CS
4-0.23-12.99435028251.771.81.45301321.63819536CS
12-0.3-16.30434782611.841.950.8001305151.40387932CS
26-0.66-302.23.080.8001171351.58331614CS
52-0.91-37.14285714292.453.30.8001117181.85979529CS
156-5.07-76.70196671716.617.8850.8001103112.78713925CS
260-5.84-79.13279132797.389.330.8001111563.90964672CS

ANEB - Frequently Asked Questions (FAQ)

What is the current Anebulo Pharmaceuticals share price?
The current share price of Anebulo Pharmaceuticals is US$ 1.54
How many Anebulo Pharmaceuticals shares are in issue?
Anebulo Pharmaceuticals has 25,933,217 shares in issue
What is the market cap of Anebulo Pharmaceuticals?
The market capitalisation of Anebulo Pharmaceuticals is USD 40.97M
What is the 1 year trading range for Anebulo Pharmaceuticals share price?
Anebulo Pharmaceuticals has traded in the range of US$ 0.8001 to US$ 3.30 during the past year
What is the PE ratio of Anebulo Pharmaceuticals?
The price to earnings ratio of Anebulo Pharmaceuticals is -4.58
What is the reporting currency for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals reports financial results in USD
What is the latest annual profit for Anebulo Pharmaceuticals?
The latest annual profit of Anebulo Pharmaceuticals is USD -8.2M
What is the registered address of Anebulo Pharmaceuticals?
The registered address for Anebulo Pharmaceuticals is 838 WALKER ROAD, SUITE 21-2, KENT, DOVER, DELAWARE, 19904
What is the Anebulo Pharmaceuticals website address?
The website address for Anebulo Pharmaceuticals is www.anebulo.com
Which industry sector does Anebulo Pharmaceuticals operate in?
Anebulo Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
NVNINVNI Group Ltd
US$ 4.38
(193.96%)
366.98M
EVAXEvaxion Biotech AS
US$ 5.99
(64.56%)
55.41M
ELABPMGC Holdings Inc
US$ 3.0901
(56.07%)
76.48M
PCLAPicoCELA Inc
US$ 4.60
(49.35%)
3.75M
GOEVCanoo Inc
US$ 0.475
(43.94%)
282.22M
GODNUGolden Star Acquisition Corporation
US$ 3.11
(-75.82%)
17.51k
GODNGolden Star Acquisition Corporation
US$ 2.93
(-65.67%)
902.76k
NXTTNext Technology Holding Inc
US$ 1.37
(-54.93%)
2.56M
SGLYSingularity Future Technology Ltd
US$ 1.625
(-38.45%)
917.77k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90.11
(-38.07%)
8
ACONAclarion Inc
US$ 0.0557
(28.94%)
811.91M
NVNINVNI Group Ltd
US$ 4.38
(193.96%)
366.98M
RIMEAlgorhythm Holdings Inc
US$ 0.0357
(4.69%)
284.97M
GOEVCanoo Inc
US$ 0.475
(43.94%)
282.22M
NVDANVIDIA Corporation
US$ 142.62
(-3.12%)
232.88M

最近閲覧した銘柄

Delayed Upgrade Clock